What Foods Should You Avoid While Taking Enzalutamide for Prostate Cancer?
You're taking enzalutamide to block the androgen receptor (AR), the main engine of your prostate cancer's growth. But could your diet be accidentally putting your foot on the gas? The foods you eat contain powerful compounds that can interact with your treatment on a molecular level. This article explains which ones to approach with caution, based on laboratory research, to help your therapy work as effectively as possible.
Key Findings
- Moringa contains ellagic acid, which activates the PI3K-Akt signaling pathway [1]—a cellular growth switch that can work against your treatment's goals.
- Blackberries contain acetaldehyde, which inhibits crucial signal transduction [3], potentially disrupting your body's anti-cancer communication.
- Bergamot contains carvacrol, which inhibits signal transduction pathways [6] that are complex and can sometimes interfere with treatment mechanisms.
Why Nutrition Matters with Enzalutamide
Prostate cancer is often driven by the androgen receptor (AR). Enzalutamide works by powerfully blocking this receptor, starving the cancer of its primary growth signal. However, cancer cells are clever and can find other ways to survive and proliferate.
Two key alternative pathways are often activated: PI3K-Akt signaling (a major growth and survival circuit) and various immune modulation pathways. Your treatment is designed to control these pathways precisely. Consuming compounds that actively stimulate growth signals like PI3K-Akt or disrupt vital communication networks can potentially provide cancer cells with a workaround, reducing the effectiveness of your therapy. The goal is to avoid accidentally activating pathways that your medication is trying to suppress.
Molecular Pathway
Foods to Approach with Caution
Moringa: The Growth Signaling Activator
Moringa is often praised as a superfood, but its compound ellagic acid has a specific mechanism that requires caution. Laboratory studies show that ellagic acid activates the PI3K-Akt signaling pathway [1]. Think of this pathway as a master switch for cell growth and survival. While this might be beneficial in some contexts, activating a major growth pathway is generally not advised when you are on a treatment designed to suppress cancer proliferation.
Ellagic acid also activates Tight junction pathways [2], which are important for cellular barriers. The net effect of consuming moringa (typically as a powder in smoothies or teas) while on enzalutamide is unclear and may be counterproductive based on this preclinical evidence.
Blackberry: Disrupting Cellular Communication
Blackberries are a common source of antioxidants, but they also contain small amounts of a compound called acetaldehyde. Research indicates that acetaldehyde inhibits signal transduction [3]. Signal transduction is how cells communicate with each other; inhibiting it can disrupt the finely tuned messages that coordinate immune responses and other vital functions.
Furthermore, acetaldehyde activates gene expression through pathways like NF-κB [4], which can influence inflammation and other processes. For someone on targeted therapy, introducing a compound that broadly disrupts cellular communication and activates inflammatory gene expression may introduce unwanted complexity.
Bergamot: Inhibiting Key Signals
Bergamot, most commonly encountered in Earl Grey tea, contains an compound called carvacrol. Studies show that carvacrol inhibits signal transduction [6], particularly through the PI3K-Akt pathway. Although inhibiting this pathway can sometimes be a goal of cancer therapy, doing so through dietary compounds is not precisely controlled.
Carvacrol also shows activity in inhibiting colorectal cancer models by affecting the gut barrier [5]. The concern is that using a blunt instrument like a dietary compound to inhibit complex signaling pathways could have unpredictable interactions with the targeted mechanism of your prescribed drug. It's best to enjoy bergamot-flavored items sparingly.
Molecular Pathway
Understanding Drug Metabolism and Interactions
Enzalutamide is a known strong inducer of the CYP3A4 enzyme. This means it tells your liver to rapidly break down other substances that are processed by this pathway.
This is crucial because many compounds, including prescription medications, over-the-counter drugs, and herbal supplements, are substrates of CYP3A4—meaning they rely on this enzyme to be broken down and cleared from your body. If you take enzalutamide, it can drastically lower the levels of these other substances, making them less effective.
For example, if you were taking a medication that is a CYP3A4 substrate (like the blood thinner apixaban or certain statins), enzalutamide could reduce its concentration to ineffective levels. This is why it is absolutely essential to discuss all medications and supplements with your oncologist and pharmacist. They can check for these interactions and adjust your regimens accordingly to ensure everything you take works as intended.
A Final Note on Your Diet
Navigating nutrition during cancer treatment can feel overwhelming. This information is not meant to cause fear but to empower you with knowledge. The interactions described are based on laboratory and preclinical research, which helps scientists understand potential mechanisms. The most important step you can take is to have an open conversation with your healthcare team about your entire diet and supplement routine. They can help you create a personalized plan that supports your health and works in harmony with your life-saving treatment.
Want recommendations personalized to your exact diagnosis?
addon scores every food and supplement against your specific cancer type, treatment regimen, and genetic mutations — backed by the same evidence you see in this article.
Get your free preview